Skip to content

Vericel VCEL Return on equity

Return on equity at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
6.1%-1.2pp
LeMaitre Vascular logo
LeMaitre VascularLMAT
16.5%+2.8pp
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-56.4%-11.3pp
Globus Medical logo
Globus MedicalGMED
13.3%+8.7pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.06B-26.8%
Enterprise value$2.05B-28.0%
P/E96.1×-850×
P/S7.1×-4.7×

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on trailing twelve months.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's return on equity?
Vericel (VCEL) reported return on equity of 6.6% in Q1 2026.
How has Vericel's return on equity changed year-over-year?
Vericel's return on equity increased by 485.4% year-over-year, from 1.1% to 6.6%.
What is the long-term trend for Vericel's return on equity?
Over 2 years (2020 to 2025), Vericel's return on equity has grown at a 47.9% compound annual growth rate (CAGR), from 2.3% to 5.1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.